Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

Clinical trial NCT02651376 · COMPLETED

Trial details

NCT number: NCT02651376
Sponsor: Beijing 302 Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Immunodeficiency

Start date: 2015-09-01
Primary completion: 2017-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.